Asthma: pathogenesis and novel drugs for treatment
JT Olin, ME Wechsler - Bmj, 2014 - bmj.com
Asthma affects almost 20 million people in the United States and more than 300 million
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
Asthma: pathogenesis and novel drugs for treatment
JT Olin, ME Wechsler - BMJ (Clinical research ed.), 2014 - pubmed.ncbi.nlm.nih.gov
Asthma affects almost 20 million people in the United States and more than 300 million
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
Asthma: pathogenesis and novel drugs for treatment
JT Olin, ME Wechsler - British medical journal, 2014 - hero.epa.gov
Asthma affects almost 20 million people in the United States and more than 300 million
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
[引用][C] Asthma: pathogenesis and novel drugs for treatment
JT Olin, ME Wechsler - BMJ, 2014 - cir.nii.ac.jp
Asthma: pathogenesis and novel drugs for treatment
JT Olin, ME Wechsler - BMJ: British Medical Journal, 2014 - JSTOR
Asthma affects almost 20 million people in the United States and more than 300 million
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
Asthma: pathogenesis and novel drugs for treatment.
JT Olin, ME Wechsler - BMJ (Clinical Research ed.), 2014 - europepmc.org
Asthma affects almost 20 million people in the United States and more than 300 million
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
Asthma: pathogenesis and novel drugs for treatment
JT Olin, ME Wechsler - BMJ, 2014 - bmj.com
Asthma affects almost 20 million people in the United States and more than 300 million
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
Asthma: pathogenesis and novel drugs for treatment
JT Olin, ME Wechsler - BMJ: British Medical Journal (Online), 2014 - search.proquest.com
Asthma affects almost 20 million people in the United States and more than 300 million
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …